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ABSTRACT
Objectives: To synthesise contributing factors leading
to medicine-related problems (MRPs) in adult patients
with cardiovascular diseases and/or diabetes mellitus
from their perspectives.
Design: A systematic literature review of qualitative
studies regarding the contributory factors leading to
MRPs, medication errors and non-adherence, followed
by a thematic synthesis of the studies.
Data sources: We screened Pubmed, EMBASE, ISI
Web of Knowledge, PsycInfo, International
Pharmaceutical Abstract and PsycExtra for qualitative
studies (interviews, focus groups and questionnaires of
a qualitative nature).
Review methods: Thematic synthesis was achieved
by coding and developing themes from the findings of
qualitative studies.
Results: The synthesis yielded 21 studies that satisfied
the inclusion and exclusion criteria. Three themes
emerged that involved contributing factors to MRPs:
patient-related factors including socioeconomic factors
(beliefs, feeling victimised, history of the condition, lack
of finance, lack of motivation and low self-esteem) and
lifestyle factors (diet, lack of exercise/time to see the
doctor, obesity, smoking and stress), medicine-related
factors (belief in natural remedies, fear of medicine, lack
of belief in medicines, lack of knowledge, non-
adherence and polypharmacy) and condition-related
factors (lack of knowledge/understanding, fear of
condition and its complications, and lack of control).
Conclusions: MRPs represent a major health threat,
especially among adult patients with cardiovascular
diseases and/or diabetes mellitus. The patients’
perspectives uncovered hidden factors that could cause
and/or contribute to MRPs in these groups of patients.
INTRODUCTION
Medicine-related problems (MRPs) emerged
as a concept in the early 1990s as “the
detrimental experience regarding drug
therapy, which potentially or actually causes
an interference with its desired outcome.”1
MRPs affect healthcare and economic situa-
tions and contribute to a tremendous
increase in morbidity, mortality and health-
care expenditure worldwide.2–4
MRPs represent a major issue, particularly
in chronic conditions such as cardiovascular
diseases (CVDs) and diabetes mellitus (DM).5
The aforementioned conditions are expected
to be the major source of morbidity by
2020.6 7 In addition, these two conditions are
interrelated; it has been documented that
DM is a key factor that leads to CVDs, as
people with diabetes are three to four times
more likely to have a CVD.8 9 Consequently,
the combination of CVDs and DM, which can
Strengths and limitations of this study
▪ To the best of our knowledge, it is the first sys-
tematic review conducted on qualitative research
regarding the contributory factors leading to
medicine-related problems from the perspectives
of adult patients with cardiovascular diseases
and diabetes mellitus.
▪ The study undertook a comprehensive systematic
review with a thematic synthesis approach.
▪ Despite using studies from 12 countries, the
analytical themes developed from the review
comprised a high level of conceptual thinking
that could be applied across different studies.
▪ The review was restricted to the experiences of
patients from 12 countries, which could limit the
generalisability of the findings.
▪ The qualitative studies (n=21) in the literature
were limited, so further qualitative studies are
needed to assess the contributory factors
leading to medicine-related problems.
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result in multiple complications, represents a major
concern for healthcare professionals.
More speciﬁcally, patients with CVDs and/or DM are
more susceptible to MRPs due to long-term use of medi-
cines and the inevitable polypharmacy.7 10 11 However,
many additional factors that contribute to MRPs in
patients with CVDs and/or DM have gone under-
reported.
Studies in the literature, which investigated risk factors
contributing to MRPs in patients with CVDs/DM, were
mainly quantitative; only a few studies were qualitative.
Quantitative studies investigating risk factors contribut-
ing to MRPs involved either direct observations or were
made retrospectively using data extracted from medical
records.12–15 However, most of the studies reported old
age and polypharmacy extensively; few studies reported
gender, depression, education, cohabitation and immo-
bilisations.16 Nonetheless, qualitative studies investigating
contributory risk factors leading to MRPs have been
rather limited.
Therefore, this review aims to explore and evaluate
contributory factors leading to MRPs among adult
patients with CVDs and/or DM from their perspectives.
METHODS
We searched the PubMed, EMBASE, ISI Web of
Knowledge, PsycInfo, International Pharmaceutical
Abstract and PsycExtra databases for entries between
January 1990 and March 2014. The search strategy evalu-
ated articles obtained predominantly through databases.
Additional articles were retrieved through the bibliog-
raphy lists of published reviews, where applicable.
The search strategy combined established methodo-
logical terms for qualitative research (qualitative
research, qualitative studies, nursing methodological
research, narrative analysis) and the following terms:
Medicine (drug/medication) related problems, medicine
(drug/medication) use, diabetes mellitus, cardiovascular
diseases, patients’ perspectives, patients’ beliefs, patients’
attitudes, patients’ views, patients’ opinions, patients’
knowledge, patients’ behaviours and contributory factors.
In addition, Medical Subject Headings (MeSH) relating
to MRPs, CVDs/DM, risk factors and patients’ perspec-
tives were explored.
Study selection
We included studies that utilised phone interviews,
face-to-face interviews, focus groups and open-ended
questionnaires published in peer-reviewed journals.
The inclusion criteria involved studies focusing on
patients’ perspectives on the use of medicines and MRPs
and were conducted on adult patients with CVDs and/
or DM.
On the other hand, the exclusion criteria ﬂagged
studies that were quantitative in nature, studies with
closed-ended questionnaires and studies focusing on
conditions other than CVD/DM.
Initially, one reviewer (AA) conducted the search and
screened titles. At this stage, studies with irrelevant titles
were excluded. Next, the abstracts of the remaining
studies were evaluated independently for inclusion by
two reviewers (MG and ZA). Any disagreements that
were encountered were resolved via a discussion. No lan-
guage limits were applied. However, the search results
only generated English studies. Figure 1 demonstrates
the details of the data extraction process.
Data synthesis and analysis
In order to extract data from articles, we adopted the sys-
tematic review approach for qualitative research by
Dixon-Woods et al.17 This allowed the emergence of
Figure 1 Data extraction and study selection process. CVD, cardiovascular diseases, DM, diabetes mellitus.
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broad concepts. Then, data was synthesised by utilising
the thematic analysis approach,18 which enables extrac-
tion of concepts and hypotheses from multiple qualita-
tive studies.
Based on the extracted results, we developed textual
summaries and tables. From the textual summaries and
tables, we identiﬁed emerging themes which described
the meaning and content of the included studies. We
then inspected similarities and differences across the
textual summaries in order to avoid contradiction and
reduce the developed number of themes. Subsequently,
we agreed on the ﬁnal list of themes through discussion
and consensus.
Finally, we coded the full list of papers for the pres-
ence or absence of themes. The codes were tabulated
afterwards by country in order to inspect similarities and
differences across countries.
Since our approach was qualitative, the presence of a
theme in more than one paper did not indicate its
importance in the studied population.19 However, a
theme appearing in more than one paper did denote to
a degree its validity. Thus, the number of studies within
a speciﬁc theme was reported in this review.
Quality of synthesis assessment
The quality of papers was assessed using the checklist
developed by Dixon-Woods et al.17 This assessment was
based mainly on clarity, consideration of ethical issues,
and transferability of the sample data and analysis
across different settings. Furthermore, the critical
appraisal skills programme criteria20 were used to rank
the papers based on 10 questions that fulﬁlled the
clarity, methods and results of the studies.
Consequently, studies were grouped into low (one star:
0–3 points), medium (two stars: 4–7 points) and high
quality (three stars: 8–10 points). Low-quality studies
were not excluded, but caution was taken when inter-
preting their results.
RESULTS
A total of 21 studies (including 836 participants) from
12 countries met the inclusion criteria (table 1) and
were conducted in the following countries: Australia,21
Brazil,22 Cameroon,23 Canada,24 Croatia,25 Ireland,26
Malaysia,27 28 South Africa,29 Spain,30 Taiwan,31 the
UK7 32–37 and the USA.38–40 The majority of the studies
investigated type 2 DM (n=15); fewer studies investigated
CVDs. Thus, only two studies investigated hypertension
(HTN), one investigated heart failure and one studied
CVDs in general. The remaining two studies investigated
DM/HTN and DM/HTN/stroke, respectively. Eight
studies used focus groups, 12 used interviews and one
study used a mixture of these methods. The review
covered areas related to patients, conditions and
medicines.
Narrative synthesis
The main ﬁndings of the review showed that contribu-
tory factors to MRPs involved three themes: patient-
related (socioeconomic and lifestyle), medicine-related
and condition-related factors. Table 2 lists the studies
that reported or discussed each theme.
Patient-related factors
Socioeconomic-related factors
Patients from six countries reported socioeconomic
factors leading to MRPs in DM and CVDs, including:
beliefs, family history of the condition, poor ﬁnances,
relationships with healthcare professionals (lack of com-
munication and not enough education), inadequate
knowledge and low self-esteem (table 2).
Beliefs regarding CVDs/DM were reported as a
problem in three studies from the UK.32 34 36 Patients
perceived that DM was given by God and higher powers
had control over their condition. One patient reported:
‘God has given me this disease of sugar. Whatever
happens, it happens because God wants it to happen.’
Moreover, a family history of DM was reported in
three studies from the UK34 36 and the USA.38
In addition, poor ﬁnances were reported by patients
in four studies from Ireland,26 South Africa,29 Croatia25
and the USA.39 A lack of necessary ﬁnances prevents
patients from buying the appropriate food (for their
diet)29 and from going to doctors.26
Consequently, the ﬁnancial situation implicated the
relationship of the patients with the healthcare profes-
sionals. Patients have reported that they were not getting
value for their money from healthcare providers.26 For
instance, one patient reported:
I don’t mind paying when I’m sick, but it’s very expensive
to pay the GP when I’m only getting a check-up with the
nurse.
Thus, the patients felt victimised by healthcare profes-
sionals25 26 29 and reported a lack of communication
with healthcare professionals.18 They described doctors
as either too busy to see them26 27 or not giving enough
information about diagnosis and medicines.32 33 37
Other patients reported having been belittled by
doctors.25 In another study, patients accounted for the
lack of communication with healthcare professionals
due to language barriers.33
Subsequently, patients reported a lack of knowledge as
a major cause for type 2 DM.25 This situation led to the
lack of motivation about their disease and affected the
intake of medicines. Patients asserted the need for
further education and training about their condition.
A lack of knowledge resulted in patients’ low-self
esteem because of their condition.25 40 Hence, patients
felt unaccepted socially, less comfortable with their col-
leagues and less worthy, from being diabetic.25 40
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Table 1 Characteristics of the included studies
Study Country Study type
Patients’
diagnosis
Method of
analysis Study population Study settings Study aims
Study
quality
Al-Qazaz et al27 Malaysia Semistructured
interviews
Type 2 DM Content
analysis
12 diabetic patients, with
at least 1 year of
diabetes and a
prescription of oral
hypoglycaemic
USM Health Clinic To explore diabetic
patients’ experience and
knowledge about
diabetes and its
medication and to
understand the factors
contributing to
medication adherence in
Malaysian population
**
Brown et al32 UK One-to-one
interviews
Type 2 DM Thematic
analysis
17 African–Caribbean
diabetes patients aged
above 18 years; 13 first
generation immigrants
and four
second-generation
immigrants
Inner city Nottingham To gain an
understanding of how
health beliefs influence
the way African–
Caribbean people with
diabetes manage their
illness
***
Choudhury et al33 UK Structured interview Type 2 DM Thematic
analysis
14 invited Bangladeshi
individuals, (4 males and
10 females), aged
between 26 to 67 years,
with type 2 DM (had it
from six months—
27 years) and were
recruited either in
Swansea or Birmingham.
Interviews were made in
either English or in
Sylheti as the researcher
was bilingual
Participants from local
communities in
Swansea and
Birmingham were invited
for the interview
To examine the
understanding and
beliefs of people with
diabetes from the
Bangladeshi community
living in the UK
**
Coronado et al38 USA Focus groups Type 2 DM Matrix
analysis by
Morgan
and
Krueger
42 individuals (14 men
and 28 women) in six
focus groups, who had
diabetes, had a family
history of diabetes, or
knew someone who had
diabetes
Fred Hutchinson Cancer
Research Center’s
project office in
Sunnyside, Yakima
Village and Skagit
Valley Community
College and at the
Catholic Church in
Burlington
To investigate the
perceptions about the
causes of and
treatments for type 2 DM
*
Continued
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Table 1 Continued
Study Country Study type
Patients’
diagnosis
Method of
analysis Study population Study settings Study aims
Study
quality
Cottrell et al21 Australia Structured interview HF Repertory
grid
technique
92 patients (older than
18 years) with heart
failure
Heart Failure Service
outpatient clinic, Royal
Brisbane and Women’s
Hospital in Brisbane,
Australia
To elicit individuals’
beliefs about their heart
failure treatment and to
investigate whether
generated constructs
were different between
adherent and
non-adherent patients
*
Gascon et al30 Spain Focus groups with
open ended
questions
HTN Thematic
analysis
Seven focus groups of
44 patients (24 men and
20 women), diagnosed
with hypertension,
between the ages of 18
and 80 years, being
treated with
antihypertensives for
3 months, being
non-compliant and
having sufficiently good
physical and mental
health to participate
Two primary healthcare
centres
To identify factors
related to
non-compliance with the
treatment of patients with
hypertension
**
Gordon et al7 UK Face-to-face
interviews
CVD Thematic
analysis
98 patients (41 males
and 57 females) aged
between 32–89 years
Home interviews of
patients recruited from
five general surgeries
and pharmacy
interviews at four
community pharmacies
To examine
medication-related
problems from the
perspective of patients
with a chronic condition
and to identify how they
may be supported in
managing their
medication
**
Grace et al34 UK Focus groups Type 2 DM Thematic
analysis
17 focus groups of adult
diabetic patients
Tower Hamlets, a
socioeconomically
deprived
London borough
To understand lay
beliefs and attitudes,
religious teachings and
professional perceptions
in relation to diabetes
prevention in the
Bangladeshi community
***
Continued
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Table 1 Continued
Study Country Study type
Patients’
diagnosis
Method of
analysis Study population Study settings Study aims
Study
quality
Heymann et al35 UK Focus groups DM and
HTN
Thematic
analysis
10 focus groups of 86
patients (42 males and
44 females) with
hypertension in three
age ranges: 41–50,
51–60, 61–70 years (six
groups); and patients
with hypertension and
DM in the age ranges:
51–60, 61–70 years
(a total of four groups)
UK To explore beliefs and
perceptions regarding
hypertension and to gain
an understanding of
barriers to treatment
among patients with and
without DM
***
Hu et al39 USA Focus groups Type 2 DM Content
analysis
Five focus groups of 73
Hispanic immigrants;
18 years or older
Free health clinic in
central North Carolina
To explore perceived
barriers among Hispanic
immigrants with diabetes
and their family
members
**
Jolles et al24 Canada Semistructured
interviews
HTN Thematic
analysis
26 patients, aged
between 26–85 years
and 62% females, able
to speak, read and write
English; diagnosed with
hypertension by a
healthcare provider, and
currently taking an
antihypertensive
medication
Two hypertension clinics
at the University of
Alberta in Edmonton
To understand
hypertensive patients’
perspectives regarding
blood pressure and
hypertension treatment
**
Kiawi et al23 Cameroon In-depth interviews,
semi-structured
Type 2
DM, HTN
and stroke
Content
analysis
15 interviews of 62
patients (27 women and
five men); selection
criteria included: having
lived at least six months
in the community, being
nominated by other
community members,
and aged above
15 years
Four urban health
districts, one from each
of the main ecological
areas of Cameroon
To investigate the lay
knowledge, attitudes and
behaviours relating to
diabetes and its main
risk factors of urban
Cameroonians
***
Continued
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Table 1 Continued
Study Country Study type
Patients’
diagnosis
Method of
analysis Study population Study settings Study aims
Study
quality
Lai et al31 Taiwan In-depth interviews Type 2 DM Thematic
analysis
22 diabetic patients
(12 males and 10
females), aged between
44–80 years, with a
duration of illness more
than 1 year
Rural Taiwan community To investigate Chinese
diabetic patients’
perceptions about their
illness and treatment
strategies to facilitate
patient-centred,
culture-sensitive clinical
skills
**
Lawton et al36 UK In-depth interviews
with open-ended
approach
Type 2 DM Thematic
analysis
31 patients (23 Pakistani
and eight Indian), aged
18 years and over, and
diagnosed with type 2
DM
General practices in
Edinburgh
Patients’ perception and
practical considerations
**
Mohd Ali and Jussoff
200928
Malaysia In-depth
open-ended
interviews
Type 2 DM Thematic
analysis
18 patients (9 males and
9 females) aged
between 15–75 years
and 13 healthcare
professionals (9 doctors,
three pharmacists and
one diabetic nurse
educator)
Endocrinology clinic of a
teaching hospital in
Kuala Lumpur
To explore the
perspectives and
experiences of Malay
patients in managing
type 2 DM as a chronic
illness and to provide
recommendations that
aim to enhance
adherence to treatment
and help patients to
improve their
self-management skills
***
Mshunqane et al29 South
Africa
Patient focus
groups (n=10) and
healthcare
professional focus
groups (n=8) and
in-depth interviews.
The questions were
open-ended
Type 2 DM Thematic
analysis
Patients who had been
diagnosed with type 2
diabetes for at least
1 year, and were aged
between 30 and 65 years
Dr George Mukhari
Hospital outpatients’
diabetes clinic
To determine the
knowledge that patients
with type 2 DM have
about the management
of their disease, as well
as the perceptions of the
healthcare team about
the services given to
patients
***
Peel et al37 UK In-depth interviews Type 2 DM Thematic
analysis
40 newly diagnosed type
2 DM patients aged
between 21–77 years
Across the Lothian
region in Scotland
To explore the patients’
emotional reactions
about their type 2 DM
diagnosis, and their
views about information
provision at the time of
diagnosis
**
Continued
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Table 1 Continued
Study Country Study type
Patients’
diagnosis
Method of
analysis Study population Study settings Study aims
Study
quality
Peres et al22 Brazil Interviews Type 2 DM Content
analysis
24 diabetic females,
aged between 25 and 76
years old, literate, with
eight years of schooling,
from Ribeirão Preto, who
perform household
activities
Nursing Education
Center for Adults and
Elderly—CEEAI,
University of São Paulo
Identify the difficulties
patients encounter when
controlling diabetes
**
Rustveld et al40 USA Focus groups Type 2 DM Thematic
analysis
34 patients in six focus
groups (three in English
and three in Spanish),
older than 18 years and
with type 2 DM
Three HCHD community
health centres in
Houston, Texas, USA
To elicit attitudes,
attributions and
self-efficacy related to
diabetes self-care in
English- as well as
Spanish-speaking
Hispanic men
**
Smith et al26 Ireland Focus groups Type 2 DM Thematic
analysis
25 patients from three
general practices, having
DM for at least 1 year
Patients were invited to
participate in the focus
group
To explore the views and
health beliefs of patients
with type 2 DM who had
experienced a new
structured diabetes
shared care service
**
Vinter-Repalust et al25 Croatia Focus groups Type 2 DM Thematic
analysis
Seven focus groups of
49 patients (22 males
and 27 females), age
range 44–83 years,
ambulatory patients with
the diagnosis of type 2
DM, with differences not
only in age and sex, but
in the method of
treatment of diabetes as
well
Zagreb Medical School To explore type 2
diabetic patients’
attitudes, thoughts and
fears connected with
their illness; their
expectations of the
healthcare system; and
the problems they
encountered while
adhering to the
therapeutic regimen
***
CVD, cardiovascular diseases; DM, diabetes mellitus; HCHD, Harris County Hospital District; HTN, hypertension; USM, Universiti Sains Malaysia.
Studies were grouped into low (one star: 0–3 points), medium (two stars: 4–7 points) and high quality (three stars: 8–10 points).
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Table 2 Themes and subthemes emerging from the studies
Theme/subtheme Countries, studies
Patient-related factors (socioeconomic)
Belief UK (Brown et al,32 Grace et al,34
Lawton et al36)
Family history of condition UK (Grace et al,34 Lawton et al36),
USA (Coronado et al38)
Feeling victimised South Africa (Mshunqane et al29),
Croatia (Vinter-Repalust et al25), Ireland (Smith et al26)
Lack of finance Ireland (Smith et al26), South Africa (Mshunqane et al29), Croatia (Vinter-Repalust
et al25), USA (Hu et al39)
Lack of knowledge Croatia (Vinter-Repalust et al25)
Lack of motivation Croatia (Vinter-Repalust et al25)
Lack of information/understanding from
doctors
UK (Brown et al,32
Choudhury et al33)
Low self-esteem Croatia (Vinter-Repalust et al25),
USA (Rustveld et al40)
Patient-related factors (life-style)
Decrease alcohol intake Canada ( Jolles et al24),
Decrease caffeine intake Canada ( Jolles et al24),
South Africa (Mshunqane et al29)
Diet Australia (Cotrell et al21),
Brazil (Peres et al22), Canada ( Jolles et al24), Croatia (Vinter-Repalust et al25),
Ireland (Smith et al26), UK (Brown et al,32 Choudhury et al,33 Grace et al,34
Heymann et al,35 Lawton et al36), USA (Coronado et al,38 Hu et al,39 Rustveld
et al40), South Africa (Mshunqane et al29), Taiwan (Lai et al31)
Lack of exercise Brazil (Peres et al22), Canada ( Jolles et al24), UK (Brown et al,32 Choudhury
et al,33 Grace et al,34 Heymann et al,35 Lawton et al36), South Africa (Mshunqane
et al29), USA (Coronado et al,38 Hu et al,39 Rustveld et al40)
Lack of time to see doctor Malaysia (Al-Qazaz et al27)
Obesity Brazil (Peres et al22),
South Africa (Mshunqane et al29),
UK (Brown et al32), USA (Coronado et al38)
Smoking Canada ( Jolles et al24),
UK (Heymann et al35)
Stress Ireland (Smith et al26),
UK (Brown et al,32 Grace et al,34 Heymann et al35), USA (Coronado et al38)
Medicine-related factors
Belief in natural remedies as alternative
to medicines
Spain (Gascon et al30),
UK (Brown et al32), USA (Coronado et al38)
Difficulty/refusal to take medicine Brazil (Peres et al22),
Croatia (Vinter-Repalust et al25)
Fear of being stuck with medicines
throughout life
Spain (Gascon et al30),
UK (Gordon et al7)
Fear of side effects Ireland (Smith et al26), Malaysia (Al-Qazaz et al27), UK (Heymann et al35),
Spain (Gascon et al30), Taiwan (Lai et al31)
Fear of the chemical nature of medicines Taiwan (Lai et al31), UK (Brown et al32)
Forgetfullness Brazil (Peres et al22), Malaysia (Al-Qazaz et al,27 Mohd Ali and Jusoff 200928),
Spain (Gascon et al30)
Lack of belief in medicines Australia (Cotrell et al21)
Lack of knowledge about medicines’
mechanism of actions
Canada ( Jolles et al24),
Spain (Gascon et al30), UK (Gordon et al7)
Non-adherence Canada ( Jolles et al24), Croatia (Vinter-Repalust et al25), Taiwan (Lai et al31),
UK (Gordon et al7), USA (Hu et al,39 Rustveld et al40)
Polypharmacy Brazil (Peres et al22)
Condition related factors
Lack of control over condition Brazil (Peres et al22), Ireland (Smith et al26)
Lack of knowledge/understanding of
condition
Australia (Cotrell et al21), Cameroon (Kiawi et al23), Canada ( Jolles et al24),
Malaysia (Al-Qazaz et al,27 Mohd Ali and Jusoff 200928), Spain (Gascon et al30),
UK (Brown et al,32 Choudhury et al,33 Heymann et al,35 Peele et al37),
USA (Coronado et al38)
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Lifestyle-related factors
Lifestyle-factors were reported in studies from 11 coun-
tries and included: diet (excessive alcohol/caffeine
intake), lack of exercise, lack of time to see the doctor,
obesity, smoking and stress.
Diet was a major issue stated in 16 studies (table 2). In
this respect, patients had different behaviours towards
their diet. For instance, one group of patients admitted
the importance of a healthy diet, yet could not control
their diets.22 31–33 Thus, one participant reported22:
Regarding the diet, I try to ﬁght so as not to eat certain
foods, but sometimes I can’t help myself.
In this respect, patients appreciated the importance of
a healthy diet in controlling DM,32 yet overestimated its
importance to be beyond medicines.31 They were also
aware that a poor diet, including excess alcohol24 and
caffeine intake,24 29 exacerbated their conditions.
Another group of patients misunderstood the concept
of a healthy diet. They believed that eating bitter foods
could control DM,33 or applied portion sizes to their
diets.40 In the latter case, patients had difﬁculty eating
smaller portions and/or even changing their favourite
foods. On other occasions, patients claimed that diet
quality was responsible for DM.26
In addition, a lack of exercise was reported in 11
studies from ﬁve countries, including Brazil,22 Canada,24
the UK,32–36 South Africa29 and the USA.38–40 A group of
patients overestimated the importance of exercise, claim-
ing that it can cure any existing disease.31 Patients
reported difﬁculty exercising although they were aware of
its importance.36 40 They justiﬁed their work, travel,
stress, the weather and lack of time as the reasons behind
their decreased physical exercise.22 33 34 36 39 A lack of
time was more reported in women whose culture
expected them to stay indoors after they got married.36
Moreover, obesity was described in four studies
(Brazil,22 South Africa,29 the UK32 and the USA38) as a
cause of DM. Patients blamed weight gain as the cause
for their increase in blood glucose level and diabetic
complications.32 38 Moreover, they attributed insulin to
be one of the causes of obesity.32
Stress emerged in ﬁve studies from three countries,
including Ireland,26 the UK32 34 35 and the USA.38 Stress
was identiﬁed as a result of changes in culture and
climate, poor housing and migration of ethnic minor-
ities.38 Patients considered stress to be a major cause of
their condition.26 32 34 35 38 40 For instance, one patient
reported:
In 1998, my mother died, and I was unable to go to the
funeral. During these months, I developed diabetes.
Patients also perceived that stress control could be an
effective way to cure their condition34 since stress led to
a poor diet, smoking and a lack of exercise.
Medicine-related factors
Medicine-related factors were found in 14 studies from
11 countries and included two types of factors: those
related to the use of medicines and those related to
knowledge about medicines.
Factors related to the use of medicines included medi-
cine non-adherence and polypharmacy. Medicine non-
adherence was reported in 10 studies from seven coun-
tries, including Brazil,22 Canada,24 Croatia,25
Malaysia,27 28 Spain,30 Taiwan,31 the UK7 and the
USA.39 40 Patients justiﬁed non-adherence to medicines
as difﬁculty following the treatment regimen,25 depres-
sion and stress,40 forgetfulness in taking the medi-
cines,7 22 27 28 30 a lack of routine in taking the
medicines,24 changes in medicine routines24 and the
inconvenience of taking insulin. For instance, patients
asserted that oral hypoglycaemics are more convenient to
take than insulin30:
I prefer pills more than insulin. You know, swallowing a
pill causes no pain. And when I know I will eat more I
just take another pill or an extra half.
Furthermore, intentional non-adherence was reported
in some studies where patients changed their insulin
doses depending on their food regimen.30 In another
scenario, patients stopped taking their medicines when
they exercised, acting on the assumption that exercise
reduces blood sugar level. Thus, patients changed the
dose/regimen of their medicines to ﬁt with their daily
activities.7
Poylpharmacy was reported among patients with type 2
DM in two studies from Brazil22 and Canada.28
Polypharmacy caused inconvenience in taking medicines22:
Medication: this has been my biggest problem in this
current phase. I take medication for blood pressure, cir-
culation, diabetes, vitamins. I used to mix up the time of
each, but today, thanks to orientation, I’m overcoming
this stage.
Factors relating to knowledge about medicines
included lack of knowledge about how the medicines
Table 2 Continued
Theme/subtheme Countries, studies
Fear of condition, its causes and
complications
South Africa (Mshunqane et al29),
UK (Choudhury et al,33 Lawton et al 200636), USA (Coronado et al38)
Stress from condition Croatia (Vinter-Repalust et al25)
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worked, fear of the chemical nature of medicines and
their side effects and a lack of belief in medicine.
The lack of knowledge about how medicines worked
was described in three studies in Canada,24 the UK7 and
Spain.30 Patients could not identify most of their medi-
cines apart from the diuretics, which they called ‘water
pills.’24 Moreover, patients could not understand how
their medicines worked, even when they read the
patient information leaﬂet.30
This lack of knowledge created fear in patients regard-
ing the chemical nature of medicines, the side effects of
medicines and being obliged to take medicines all of
their lives.7 26 27 30–32 35 For instance, patients referred
to oral hypoglycaemic agents and insulin as ‘pharma-
ceutical toxins.’31
Additionally, patients were afraid of the side effects
and complications of medicines. They attributed various
side effects to medicines, including hypoglycaemia and
gastrointestinal disturbances to insulin,32 kidney failure
to oral hypoglycaemic agents,31 and nausea/vomiting to
antihypertensive agents.30 In the last case, a patient
reported:
I don’t like them (medicines); they have lots of side
effects. They can make you sick… I think that I might get
worse instead of better.
These fears promoted a lack of belief in medicines
among patients.21 Subsequently, patients started to
believe in natural remedies as an alternative to medi-
cines.30 32 38 They referred to natural therapies as ‘a
cure’ that should be used alongside traditional medi-
cines.38 In another scenario, patients believed that
natural therapies were superior to medicines.32 In this
respect, natural therapies reported for curing DM
included natural drinks (composed of minerals and
water),38 and plant products (such as aloe vera, arnica,
cactus, silk cottonwood tree, tree spinach and violet
water).32
Condition-related factors
Condition (clinical)-related factors were reported from
11 countries as a major theme. Factors included a lack
of knowledge/understanding of the condition, fear of
the condition and its complications, stress from the con-
dition and a lack of control over the condition.
Lack of knowledge/understanding of the condition
(CVDs/DM) emerged as a major theme in 11 studies
from seven countries, including Australia,21 Cameroon,23
Canada,24 Malaysia,27 28 Spain,30 the UK32 33 35 37 and the
USA.38
For CVDs, patients expressed a lack of knowledge
about their heart failure, HTN and stroke. Patients with
heart failure did not know enough about their disease
symptoms.21 Moreover, hypertensive patients did not
understand the nature of their disease,28 30 struggled to
deﬁne their condition24 and considered it an underlying
risk factor to myocardial infarction rather than a
disease.35 Patients justiﬁed their lack of knowledge by
citing short consultations with physicians, not obtaining
enough information from physicians and obtaining
information from non-medical sources such as television
and magazines. For instance, one patient reported:
Anything I know about blood pressure I’ve read in books,
the doctor tells me absolutely nothing … High blood
pressure: factors related to compliance with treatment
127. I want him to tell me where high blood pressure
comes from.
Similarly, patients with DM lacked knowledge about
the disease and misunderstood its causes and complica-
tions.23 25 27 29 32 33 36 Regarding the DM condition and
causes, patients’ perceptions of DM were inﬂuenced by
other people’s accounts and experiences.32 Patients
viewed the condition as an illness that took away their
health and strength,36 changing their lifestyle.25 They
could not differentiate between types 1 and 2 DM,27
considered high sugar intake to be the cause of DM,
and perceived DM to be sexually and genetically trans-
mitted.23 33 Moreover, patients believed that diabetes was
not dangerous if it did not require insulin.32 Patients
were only aware of the microvascular complications
(such as foot disease) of DM.26 Moreover, they were
aware of the disease’s signs and symptoms (such as dry
mouth, tiredness, dizziness, irritation, blurred vision,
micturition and extreme thirst) only after they encoun-
tered them.28 38
The lack of knowledge about the condition created
fear in patients’ minds of the disease itself38 and they
could not accept the disease easily.25 33 One patient
reported38:
Diabetes is a disease that kills you little by little.
Diseases additionally resulted in stress about the con-
dition, which was particularly observed in patients with
multiple comorbidities.36 For instance, diabetic patients
who had asthma as a comorbidity could not exercise
due to asthma symptoms, such as shortness of breath
and swollen feet and joints:
They tell you to exercise … but I can’t move around a lot
because I have a problem with my leg (arthritis). If I walk
a little, then it swells up.
As a result, patients were not able to control their con-
dition,22 26 which led to frustration, depression and
anxiety.
DISCUSSION
To the best of our knowledge, this review is the ﬁrst sys-
tematic analysis of the perspectives of adult patients with
CVDs/DM on contributory factors leading to MRPs. We
explored patients’ knowledge, beliefs and behaviours
towards medicines. The majority of studies evaluated
patients with DM; only a few studies evaluated patients
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with CVDs. The three themes emerging from this review
included: patient-related (socioeconomic-related and
lifestyle-related), clinical-related and medicine-related
factors.
Patient-related factors
Socioeconomic-related factors
Socioeconomic factors (genetic, cultural behaviour and
ﬁnancial situations) affected patients’ perceptions of
disease and the medicines contributing to MRPs.
Patients perceived genetic factors and religious beliefs to
be the cause of their DM.19 21 Patients from Christian
and Muslim backgrounds named God as the cause for
their DM. These attitudes were conﬁrmed by other
studies which showed that religious values contributed
to MRPs.41 42 In addition, patients felt socially stigma-
tised by their DM, which affected their self-esteem. They
also blamed their ﬁnancial situation for contributing to
MRPs, since their ﬁnances prevented them from having
the right diet and being able to afford doctors’ visits.
The cost of therapy has been perceived as being import-
ant, particularly with chronic conditions such as CVDs.43
Thus, the value that patients receive from healthcare
professionals for their money was unsatisfactory. In fact,
doctors’ attitudes towards the patients played an import-
ant role in patients being compliant with their regi-
mens.44 This problem was signiﬁcant in ethnic
minorities where a lack of communication between
doctors and patients lead to misunderstanding.41
Patients conﬁrmed the need for further information
and training, emphasising the importance of getting
information from healthcare professionals.
Lifestyle-related factors
Lifestyle factors were perceived as a vital component for
the control of conditions (CVDs/DM). Patients felt that
they needed to adjust their diet, engage in physical activ-
ity and manage their moods to cope with conditions. In
relation to diet, they either did not understand the
concept of a healthy diet or they had difﬁculty man-
aging a good diet. Thus, some patients assumed that a
healthy diet meant eating less food, eating ‘bitter food’
or eating ‘natural food.’ Other patients overestimated
the importance of diet as being more crucial than medi-
cines. This overestimation can be attributed to the fact
that the frequency of meals could serve as a reminder to
take medicines.43 In addition, patients were aware of the
necessity of physical exercise but blamed the weather,
work, lack of time and stress for their not exercising.43
Stress was a major factor that patients blamed for not
taking medicines on time and for eating a poor diet.
Medicine-related factors
Medicines were recognised by patients as a contributing
factor to MRPs with regard to lack of knowledge about
medicines, lack of belief that medicines are good, difﬁ-
culty taking medicines on time and fear of side effects.
Patients reported a lack of knowledge about how the
medicines worked, called them pharmaceutical toxins
and preferred herbal remedies to medicines. This point
was emphasised in another study41 that stated that
patients’ lack of awareness about the use of their medi-
cines led to MRPs. Furthermore, patients reported skip-
ping medicine doses due to forgetfulness or they did
not take their medicines on purpose (at the time of
exercise). Forgetfulness in terms of taking medicines was
observed more often in patients who did not have
regular meals.43 At other times, patients were scared of
the side effects and complications of medicines. The
medicines’ side effects caused physical discomfort for
patients, who started to doubt the therapy’s effectiveness
and skipped their medicines.43
Condition-related factors
Condition (clinical) factors reported by patients
revealed a lack of knowledge about the disease and its
cause, a lack of control over the disease and the exist-
ence of comorbidities with the disease.43 Patients were
accordingly not fully aware of their condition and per-
ceived it in most cases as being a risk factor leading to
other diseases. Moreover, they misidentiﬁed the causes
and complications of their condition. Once the educa-
tion about the condition was provided, patients felt
scared and frustrated, which induced a lack of control
over the disease. Moreover, the existence of comorbid-
ities with the main condition worsened the patients’
adherence to treatment and advice.
Strengths and weaknesses of the review
This review proposes a systematic and comprehensive
approach to qualitative studies of contributory factors to
MRPs of adult patients with CVDs/DM. We adopted a
thematic synthesis approach to eligible studies regarding
the treatment experiences from patients’ perspectives.
The studies involved 836 participants. However, despite
the diversity of the participants and different contexts in
the studies, we were able to develop themes that indi-
cated an overlap among the studies.
We used recognised methods from the literature
regarding patients’ experiences/perspectives in order to
synthesise and develop analytical themes.18 45 We
included the details of each study in relation to the
aims, participants, settings and methods applied. We
rated the studies’ qualities based on methods from
the literature. In this respect, we found that studies with
the highest ratings contributed most to the ﬁnal analyt-
ical themes.
One limitation of the review is that it was restricted to
the experiences of those patients involved in the studies.
Moreover, perspectives and beliefs of non-English speak-
ing patients and those seeking palliative care were not
integrated into this review due to lack of studies repre-
senting them. Thus, the review was extracted from
studies in 12 countries only. Therefore, the generalisabil-
ity of the ﬁndings of this review to patients from differ-
ent countries (other than the 12 aforementioned
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countries) may be difﬁcult. However, the analytical
themes developed offer a high level of conceptual think-
ing that can be applied across different contexts.
Implications of the research
This review examined the contribution of patients’ per-
ceptions, behaviours and beliefs in understanding differ-
ent aspects of underlying risk factors that may lead to
MRPs. Syntheses of the qualitative research on such risk
factors should complement the ﬁndings from quantita-
tive research. Having a systematic review when planning
new qualitative research may help to avoid unintentional
examination of questions that have already been exten-
sively researched. Finally, the ﬁndings of this study on
patients’ perspectives could better inform the develop-
ment of future screening tools and interventions for
avoiding MRPs. Additionally, our results may also
increase researchers’ knowledge of generic issues in this
ﬁeld, even when attempting to target a speciﬁc ethnic or
cultural group.
Implication towards practices
Patients’ perspectives about medicine use and factors
affecting their treatment regimen are often different
from the medical viewpoint. Worldwide, people with
CVD and/or DM widely perceive that their conditions
are principally stress-related conditions and fear addic-
tion or dependence on medicines, which leads to non-
adherence to required treatments. These misconcep-
tions and fears commonly cause people to reduce or
stop treatment. If we are to be successful at minimising
and preventing MRPs, incorporating patients’ perspec-
tives as well as considering medical records are of para-
mount concern. An increased understanding between
doctors and their patients must play a part in future
strategies for reducing MRPs in patients with CVDs and/
or DM.
CONCLUSIONS
This thematic synthesis of qualitative studies on patients’
perspectives of the potential risk factors of MRPs shows
that underlying factors that may lead to MRPs require
further in-depth research. Factors inﬂuencing patients’
success in treatment included patient-related (socio-
economic and lifestyle), medicine-related (fear of medi-
cine, non-adherence and polypharmacy) and condition-
related factors (fear of condition and its complications).
In summary, more qualitative research should be con-
ducted on patients with CVDs and/or DM to understand
and address issues related to the treatment regimens
and to subsequently reduce the cost of undesired hos-
pital admissions resulting from MRPs.
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